Chimeric Antigen Receptor T-Cell Neurotoxicity Neuroimaging: More Than Meets the Eye

References

1. 1.↵
   2. Gust J,
   3. Hay KA,
   4. Hanafi LA, et al

   . Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T Cells. Cancer Discov 2017;7:1404–19 doi:10.1158/2159-8290.CD-17-0698

   Abstract/FREE Full Text
2. 2.↵
   2. Gust J,
   3. Taraseviciute A,
   4. Turtle CJ

   . Neurotoxicity associated with CD19-targeted CAR-T cell therapies. CNS Drugs 2018;32:1091–101 doi:10.1007/s40263-018-0582-9 pmid:30387077

   CrossRefPubMed
3. 3.↵
   2. Gust J,
   3. Finney OC,
   4. Li D, et al

   . Glial injury in neurotoxicity after pediatric CD19-directed CAR-T cell therapy. Ann Neurol 2019;86:42–54 doi:10.1002/ana.25502 pmid:31074527

   CrossRefPubMed
4. 4.↵
   2. Santomasso BD,
   3. Park JH,
   4. Salloum D, et al

   . Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with b-cell acute lymphoblastic leukemia. Cancer Discov 2018;8:958–71 doi:10.1158/2159-8290.CD-17-1319 pmid:29880584

   Abstract/FREE Full Text